TRAIL (TNF-related apoptosis inducing Ligand) is a member of the TNF family involved in programmed cell death in cancer cells [207], and miR-221, miR-222 were found to guide lung cancer resistance to TRAIL therapy by downregulating PTEN and TIMP3, which are both tumor suppressors [75]. Here, TNFSF10 is linked to neoplasm.